Combination effect of the Anti-PD-1 antibody and STAT3 inhibitor, STX-0119, using humanized MHC-dKO NOG mouse

被引：0
|
作者：
Ashizawa, Tadashi [1 ]
Iizuka, Akira [1 ]
Maruyama, Koji [2 ]
Asai, Akira [3 ]
Yamaguchi, Ken [1 ]
Akiyama, Yasuto [1 ]
机构：
[1] Shizuoka Canc Ctr, Res Inst, Dept Immunother, Nagaizumi, Shizuoka, Japan
[2] Shizuoka Canc Ctr, Res Inst, Exp Anim Facil, Nagaizumi, Shizuoka, Japan
[3] Univ Shizuoka, Ctr Drug Discovery, Shizuoka, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2395
引用
收藏
页码：1032 / 1032
页数：1
相关论文
共 25 条
  • [1] Anti-immunosuppressive activity of STAT3 inhibitor, STX-0119, using humanized MHC-double knockout NOG mouse
    Ashizawa, Tadashi
    Iizuka, Akira
    Maruyama, Kouji
    Asai, Akira
    Yamaguchi, Ken
    Akiyama, Yasuto
    CANCER SCIENCE, 2018, 109 : 749 - 749
  • [2] Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line
    Ashizawa, Tadashi
    Akiyama, Yasuto
    Miyata, Haruo
    Iizuka, Akira
    Komiyama, Masaru
    Kume, Akiko
    Omiya, Maho
    Sugino, Takashi
    Asai, Akira
    Hayashi, Nakamasa
    Mitsuya, Koichi
    Nakasu, Yoko
    Yamaguchi, Ken
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (01) : 411 - 418
  • [3] Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma
    Ashizawa, Tadashi
    Miyata, Haruo
    Iizuka, Akira
    Komiyama, Masaru
    Oshita, Chie
    Kume, Akiko
    Nogami, Masahiro
    Yagoto, Mika
    Ito, Ichiro
    Oishi, Takuma
    Watanabe, Reiko
    Mitsuya, Koichi
    Matsuno, Kenji
    Furuya, Toshio
    Okawara, Tadashi
    Otsuka, Masami
    Ogo, Naohisa
    Asai, Akira
    Nakasu, Yoko
    Yamaguchi, Ken
    Akiyama, Yasuto
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 43 (01) : 219 - 227
  • [4] Novel STAT3 inhibitor, YHO-1701 enhances the antitumor effect of anti-PD-1 antibody
    Takahashi, Hiroyuki
    Murakami, Hisashi
    Ogo, Naohisa
    Muraoka, Daisuke
    Takagi, Akimitsu
    Asai, Akira
    CANCER SCIENCE, 2023, 114 : 669 - 669
  • [5] STX-0119, a novel STAT3 dimerization inhibitor, prevents fibrotic gene expression in a mouse model of kidney fibrosis by regulating Cxcr4 and Ccr1 expression
    Makitani, Kouki
    Ogo, Naohisa
    Asai, Akira
    PHYSIOLOGICAL REPORTS, 2020, 8 (20):
  • [6] The anti-tumor activity of the STAT3 inhibitor STX-0119 occurs via promotion of tumor-infiltrating lymphocyte accumulation in temozolomide-resistant glioblastoma cell line
    Akiyama, Yasuto
    Nonomura, Chizu
    Ashizawa, Tadashi
    Iizuka, Akira
    Kondou, Ryota
    Miyata, Haruo
    Sugino, Takashi
    Mitsuya, Koichi
    Hayashi, Nakamasa
    Nakasu, Yoko
    Asai, Akira
    Ito, Mamoru
    Kiyohara, Yoshio
    Yamaguchi, Ken
    IMMUNOLOGY LETTERS, 2017, 190 : 20 - 25
  • [7] Combination of a STAT3 inhibitor with anti-PD-1 immunotherapy is an effective treatment regimen for a vemurafenib-resistant melanoma
    Kim, Tae Woo
    Kim, Yujin
    Keum, Hyeongseop
    Jung, Wonsik
    Kang, Minho
    Jon, Sangyong
    MOLECULAR THERAPY-ONCOLYTICS, 2022, 26 : 1 - 14
  • [8] Impact of combination therapy with anti-PD-1 blockade and a STAT3 inhibitor on the tumor-infiltrating lymphocyte status
    Ashizawa, Tadashi
    Iizuka, Akira
    Maeda, Chie
    Tanaka, Emiko
    Kondou, Ryota
    Miyata, Haruo
    Sugino, Takashi
    Kawata, Takuya
    Deguchi, Shoichi
    Mitsuya, Koichi
    Hayashi, Nakamasa
    Asai, Akira
    Ito, Mamoru
    Yamaguchi, Ken
    Akiyama, Yasuto
    IMMUNOLOGY LETTERS, 2019, 216 : 43 - 50
  • [9] Combination effect of anti-PD-1 antibody and PDGFR inhibitor on mouse model of liver metastasis from colorectal cancer
    Kadota, Hiroki
    Yuge, Ryou
    Takigawa, Hidehiko
    Onishi, Kana
    Otani, Rina
    Kitadai, Yasuhiko
    Tanaka, Shinji
    CANCER SCIENCE, 2022, 113 : 1706 - 1706
  • [10] Combination of anti-PD-1 antibody and PDGFR inhibitor inhibits metastasis of colorectal cancer in a mouse model
    Kadota, Hiroki
    Yuge, Ryo
    Ariyoshi, Misa
    Shimizu, Daisuke
    Miyamoto, Ryo
    Ohtani, Rina
    Takigawa, Hidehiko
    Oka, Shiro
    Kitadai, Yasuhiko
    Tanaka, Shinji
    CANCER SCIENCE, 2023, 114 : 1403 - 1403
123